Detalhe da pesquisa
1.
Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen.
Clin Infect Dis
; 52(4): 547-50, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21252140
2.
Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: pharmacogenetic effect of CYP2B6 variation.
J Clin Pharmacol
; 48(9): 1032-40, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18728241